D
Enliven Therapeutics, Inc. ELVN
$18.65 -$0.09-0.48% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -94.83M -89.02M -85.21M -82.83M -79.60M
Total Depreciation and Amortization 312.00K 317.00K 315.00K 313.00K 309.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 22.96M 20.06M 15.00M 10.75M 10.29M
Change in Net Operating Assets -2.40M -4.54M 1.43M -403.00K 5.22M
Cash from Operations -73.96M -73.19M -68.47M -72.17M -63.79M
Capital Expenditure -44.00K -44.00K -58.00K -52.00K -138.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -16.64M -35.95M 2.02M -48.36M -166.13M
Cash from Investing -16.69M -36.00M 1.96M -48.41M -166.27M
Total Debt Issued -- -- -- -161.37M -162.90M
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 43.13M 133.17M 93.28M 253.56M 251.89M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 0.00 -453.00K -1.88M
Cash from Financing 43.13M 133.17M 93.28M 91.74M 87.12M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -47.51M 23.98M 26.77M -28.84M -142.94M